1 FAMOTIDINE | 970 of 4330 | 360 prescriptions Less than 1% of all prescriptions | | 240 patients 12% of all patients | < 11 | |
2 PROPRANOLOL HCL | 170 of 1540 | 340 prescriptions Less than 1% of all prescriptions | | 150 patients 7% of all patients | < 11 | |
3 SPIRONOLACTONE | 370 of 3110 | 330 prescriptions Less than 1% of all prescriptions | | 150 patients 7% of all patients | < 11 | |
4 FUROSEMIDE | 500 of 2870 | 320 prescriptions Less than 1% of all prescriptions | | 140 patients 7% of all patients | < 11 | |
5 PANTOPRAZOLE SODIUM | 2510 of 1,1170 | 570 prescriptions Less than 1% of all prescriptions | 450 | 320 patients 15% of all patients | < 11 | |
6 XIFAXAN (RIFAXIMIN) | 130 of 3950 | 820 prescriptions Less than 1% of all prescriptions | | 190 patients 9% of all patients | < 11 | A |
7 LIALDA (MESALAMINE) | 420 of 2070 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
8 ENTECAVIR | 660 of 2210 | 190 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | |
9 TENOFOVIR DISOPROXIL FUMARATE | 380 of 1310 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
10 URSODIOL | 660 of 3610 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
11 OMEPRAZOLE | 3380 of 1,1970 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
12 ENULOSE (LACTULOSE) | 20 of 50 | 210 prescriptions Less than 1% of all prescriptions | | 140 patients 7% of all patients | < 11 | |
13 LACTULOSE | 490 of 2860 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
14 METRONIDAZOLE | 360 of 2580 | 170 prescriptions Less than 1% of all prescriptions | | 160 patients 8% of all patients | < 11 | A |
15 GAVILYTE-C (PEG3350/SOD SULF,BICARB,CL/KCL) | 1050 of 3240 | 480 prescriptions Less than 1% of all prescriptions | | 460 patients 22% of all patients | < 11 | |
16 PEG 3350-ELECTROLYTE (PEG3350/SOD SULF,BICARB,CL/KCL) | 1090 of 3030 | 290 prescriptions Less than 1% of all prescriptions | | 280 patients 13% of all patients | < 11 | |